Omega Fund Management as of Dec. 31, 2022
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 16 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Imago Biosciences Common Stock | 36.6 | $109M | 3.0M | 35.95 | |
| Replimune Group Common Stock (REPL) | 30.8 | $91M | 3.4M | 27.20 | |
| Nuvation Bio Common Stock Class A (NUVB) | 9.8 | $29M | 15M | 1.92 | |
| Morphic Holding Common Stock (MORF) | 5.4 | $16M | 598k | 26.75 | |
| Alpine Immune Sciences Common Stock | 5.0 | $15M | 2.0M | 7.35 | |
| Cincor Common Stock | 2.6 | $7.9M | 561k | 14.00 | |
| Kronos Bio Common Stock (KRON) | 2.1 | $6.2M | 3.8M | 1.62 | |
| Ikena Oncology Common Stock (IKNA) | 2.0 | $6.0M | 2.2M | 2.66 | |
| Paratek Pharmaceuticals Common Stock | 1.2 | $3.7M | 2.0M | 1.87 | |
| Theseus Pharmaceuticals Common Stock | 1.2 | $3.5M | 712k | 4.98 | |
| Sana Biotechnology Common Stock (SANA) | 1.1 | $3.3M | 844k | 3.95 | |
| Immunic Common Stock (IMUX) | 0.8 | $2.5M | 1.8M | 1.40 | |
| Spruce Biosciences Common Stock (SPRB) | 0.8 | $2.3M | 2.2M | 1.08 | |
| Syros Pharmaceuticals Common Stock (SYRS) | 0.3 | $902k | 251k | 3.59 | |
| Jounce Therapeutics Common Stock | 0.1 | $306k | 276k | 1.11 | |
| Senti Biosciences Common Stock (SNTI) | 0.1 | $276k | 196k | 1.41 |
